Babina M - Search Results

1

Mas-related G protein-coupled receptor X2 and its activators in dermatologic allergies.

Kühn H, Kolkhir P, Babina M, Düll M, Frischbutter S, Fok JS, Jiao Q, Metz M, Scheffel J, Wolf K, Kremer AE, Maurer M. Kühn H, et al. Among authors: babina m. J Allergy Clin Immunol. 2021 Feb;147(2):456-469. doi: 10.1016/j.jaci.2020.08.027. Epub 2020 Oct 15. J Allergy Clin Immunol. 2021. PMID: 33071069 Review.

2

Mast cells as initiators of immunity and host defense.

Henz BM, Maurer M, Lippert U, Worm M, Babina M. Henz BM, et al. Among authors: babina m. Exp Dermatol. 2001 Feb;10(1):1-10. doi: 10.1034/j.1600-0625.2001.100101.x. Exp Dermatol. 2001. PMID: 11168574 Review.

3

Tamoxifen counteracts the allergic immune response and improves allergen-induced dermatitis in mice.

Babina M, Kirn F, Hoser D, Ernst D, Rohde W, Zuberbier T, Worm M. Babina M, et al. Clin Exp Allergy. 2010 Aug;40(8):1256-65. doi: 10.1111/j.1365-2222.2010.03472.x. Epub 2010 Mar 12. Clin Exp Allergy. 2010. PMID: 20337649

4

Mast cell transcriptome elucidation: what are the implications for allergic disease in the clinic and where do we go next?

Babina M, Motakis E, Zuberbier T. Babina M, et al. Expert Rev Clin Immunol. 2014 Aug;10(8):977-80. doi: 10.1586/1744666X.2014.933074. Epub 2014 Jul 5. Expert Rev Clin Immunol. 2014. PMID: 24998292 Review.

5

Ramipril and metoprolol intake aggravate human and murine anaphylaxis: evidence for direct mast cell priming.

Nassiri M, Babina M, Dölle S, Edenharter G, Ruëff F, Worm M. Nassiri M, et al. Among authors: babina m. J Allergy Clin Immunol. 2015 Feb;135(2):491-9. doi: 10.1016/j.jaci.2014.09.004. Epub 2014 Oct 16. J Allergy Clin Immunol. 2015. PMID: 25441633

6

Impact of sex on anaphylaxis severity--data from the Anaphylaxis Registry.

Francuzik W, Nassiri M, Babina M, Worm M. Francuzik W, et al. Among authors: babina m. J Allergy Clin Immunol. 2015 Nov;136(5):1425-6. doi: 10.1016/j.jaci.2015.06.052. Epub 2015 Sep 26. J Allergy Clin Immunol. 2015. PMID: 26392054 No abstract available.

7

Allergic FcεRI- and pseudo-allergic MRGPRX2-triggered mast cell activation routes are independent and inversely regulated by SCF.

Babina M, Guhl S, Artuc M, Zuberbier T. Babina M, et al. Allergy. 2018 Jan;73(1):256-260. doi: 10.1111/all.13301. Epub 2017 Sep 20. Allergy. 2018. PMID: 28859248

8

MRGPRX2 is negatively targeted by SCF and IL-4 to diminish pseudo-allergic stimulation of skin mast cells in culture.

Babina M, Wang Z, Artuc M, Guhl S, Zuberbier T. Babina M, et al. Exp Dermatol. 2018 Nov;27(11):1298-1303. doi: 10.1111/exd.13762. Epub 2018 Sep 3. Exp Dermatol. 2018. PMID: 30091263

9

IL-33 and MRGPRX2-Triggered Activation of Human Skin Mast Cells-Elimination of Receptor Expression on Chronic Exposure, but Reinforced Degranulation on Acute Priming.

Wang Z, Guhl S, Franke K, Artuc M, Zuberbier T, Babina M. Wang Z, et al. Among authors: babina m. Cells. 2019 Apr 11;8(4):341. doi: 10.3390/cells8040341. Cells. 2019. PMID: 30979016 Free PMC article.

10

PGE₂ deficiency predisposes to anaphylaxis by causing mast cell hyperresponsiveness.

Rastogi S, Willmes DM, Nassiri M, Babina M, Worm M. Rastogi S, et al. Among authors: babina m. J Allergy Clin Immunol. 2020 Dec;146(6):1387-1396.e13. doi: 10.1016/j.jaci.2020.03.046. Epub 2020 May 11. J Allergy Clin Immunol. 2020. PMID: 32407837

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters